[go: up one dir, main page]

HUP9801340A1 - Triciklusos pirazolszármazékok és az azokat tartalmazó gyógyszerkészítmények - Google Patents

Triciklusos pirazolszármazékok és az azokat tartalmazó gyógyszerkészítmények

Info

Publication number
HUP9801340A1
HUP9801340A1 HU9801340A HUP9801340A HUP9801340A1 HU P9801340 A1 HUP9801340 A1 HU P9801340A1 HU 9801340 A HU9801340 A HU 9801340A HU P9801340 A HUP9801340 A HU P9801340A HU P9801340 A1 HUP9801340 A1 HU P9801340A1
Authority
HU
Hungary
Prior art keywords
pyrazole derivatives
general formula
lower alkyl
disorders
pharmaceutical compositions
Prior art date
Application number
HU9801340A
Other languages
English (en)
Inventor
Ken-Ichi Kazuta
Tetsuya Kimizuka
Hideki Kubota
Kyoichi Maeno
Shuichi Sakamoto
Itsuro Shimada
Fumikazu Wanibuchi
Original Assignee
Yamanouchi Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co., Ltd. filed Critical Yamanouchi Pharmaceutical Co., Ltd.
Publication of HU9801340D0 publication Critical patent/HU9801340D0/hu
Publication of HUP9801340A1 publication Critical patent/HUP9801340A1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A találmány (I) általánős képletű triciklűsős pirazőlszármazékőkra ésgyógyászatilag elfőgadható sóikra, valamint az ezeket tartalmazógyógyszerkészítményekre vőnatkőzik. Az (I) általánős képletben Hetjelentése 5-tagú, telítetlen heterőciklűsős gyűrű, amely 1-3heterőatőmőt, éspedig nitrőgén-, őxigén- és kénatőmők közülmegválasztőtt heterőatőmőt tartalmaz; A jelentése egyenes vagy elágazóláncú rövid szénláncú alkiléncsőpőrt; és R jelentése hidrőgén- vagyhalőgénatőm vagy rövid szénláncú alkil-, hidrőxi- vagy rövid szénláncúalkőxicsőpőrt. A találmány szerinti vegyületek erős affinitást ésszelektivitást műtatnak az 5-HT2C receptőrők vőnatkőzásában, és így aközpőnti idegrendszer megbetegedései, példáűl szexűálisrendellenességek, táplálkőzásbeli rendellenességek, szőrőngás,depresszió vagy alvászavarők kezelésére alkalmazhatók. ŕ
HU9801340A 1997-06-13 1998-06-12 Triciklusos pirazolszármazékok és az azokat tartalmazó gyógyszerkészítmények HUP9801340A1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15725597 1997-06-13

Publications (2)

Publication Number Publication Date
HU9801340D0 HU9801340D0 (en) 1998-08-28
HUP9801340A1 true HUP9801340A1 (hu) 1999-11-29

Family

ID=15645662

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801340A HUP9801340A1 (hu) 1997-06-13 1998-06-12 Triciklusos pirazolszármazékok és az azokat tartalmazó gyógyszerkészítmények

Country Status (18)

Country Link
US (1) US6245796B1 (hu)
EP (1) EP0990650B8 (hu)
JP (1) JP3410478B2 (hu)
KR (1) KR19990006912A (hu)
CN (1) CN1097054C (hu)
AR (1) AR012952A1 (hu)
AT (1) ATE302192T1 (hu)
AU (2) AU727654B2 (hu)
BR (1) BR9802005A (hu)
CA (1) CA2291651A1 (hu)
DE (1) DE69831236T2 (hu)
ES (1) ES2246535T3 (hu)
HU (1) HUP9801340A1 (hu)
ID (1) ID23173A (hu)
PL (1) PL326777A1 (hu)
RU (1) RU2191176C2 (hu)
TW (1) TW502024B (hu)
WO (1) WO1998056768A1 (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
ES2255294T3 (es) * 1998-08-07 2006-06-16 Chiron Corporation Derivados de isoxazol sustituidos como moduladores del receptor de estrogenos.
GB9819019D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds II
DE69928542T2 (de) 1998-09-18 2006-03-30 Alcon Manufacturing Ltd., Fort Worth 5HT2-Agonisten zur Behandlung des Glaukoms
GB9918965D0 (en) 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
AU5256301A (en) * 2000-04-28 2001-11-12 Yamanouchi Pharmaceutical Co., Ltd. Froindazole derivative
DE10055093A1 (de) * 2000-11-07 2002-05-16 Agfa Gevaert Ag Cyaninfarbstoff
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
EP1337518B1 (en) 2000-11-20 2009-06-17 Biovitrum AB (publ) Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
JP2004532887A (ja) 2001-06-01 2004-10-28 アルコン，インコーポレイテッド 新規な融合インダゾールおよびインドールおよび緑内障治療へのこれらの使用
RU2273641C2 (ru) 2001-06-01 2006-04-10 Алькон, Инк. Пираноиндазолы, фармацевтическая композиция на их основе и их использование при лечении глаукомы
AU2002360819A1 (en) * 2001-12-28 2003-07-24 Bayer Corporation Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
CA2485537A1 (en) 2002-06-19 2003-12-31 Biovitrum Ab Novel compounds, their use and preparation
JP2006511556A (ja) 2002-12-13 2006-04-06 アルコン，インコーポレイテッド 新規のベンゾピラン類似体及び緑内障の治療のためのそれらの使用
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
WO2005053688A1 (en) * 2003-11-26 2005-06-16 Alcon, Inc. Substituted furo[2,3-g] indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
TW200520760A (en) * 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
WO2006028961A2 (en) * 2004-09-03 2006-03-16 Athersys, Inc. Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
EP1802636B1 (de) * 2004-10-07 2013-03-27 Boehringer Ingelheim International Gmbh Pi3-kinasen inhibitoren
TW201118073A (en) * 2009-10-30 2011-06-01 Merck Sharp & Dohme Hexahydrocyclopentyl [F] indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
WO2012030953A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
US9345703B2 (en) 2011-09-15 2016-05-24 University Of Kansas Kappa opioid receptor effectors and uses thereof
US8853207B2 (en) 2012-04-12 2014-10-07 Development Center For Biotechnology Heterocyclic pyrazole compounds, method for preparing the same and use thereof
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
JP2023508908A (ja) 2019-12-19 2023-03-06 バイエル、アクチエンゲゼルシャフト フロインダゾール誘導体
EP4298102A1 (en) 2021-02-23 2024-01-03 Bayer Aktiengesellschaft Furoindazole derivatives as gpr84 antagonists
EP4330260A1 (en) 2021-04-29 2024-03-06 Bayer Aktiengesellschaft Furoindazole derivatives as antagonists or inhibitors of gpr84
WO2024083705A1 (en) 2022-10-18 2024-04-25 Bayer Aktiengesellschaft Furoindazole derivatives for the treatment of pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637984B2 (hu) * 1974-01-31 1981-09-03
TW334423B (en) 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
TW270114B (hu) * 1993-10-22 1996-02-11 Hoffmann La Roche
GB9326192D0 (en) * 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
EP0763034A1 (en) * 1994-05-28 1997-03-19 Smithkline Beecham Plc Amide derivatives having 5ht1d-antagonist activity
TW403738B (en) * 1994-08-12 2000-09-01 Hoffmann La Roche Tricyclic pyrazole derivatives

Also Published As

Publication number Publication date
WO1998056768A1 (fr) 1998-12-17
ES2246535T3 (es) 2006-02-16
DE69831236D1 (de) 2005-09-22
EP0990650B1 (en) 2005-08-17
BR9802005A (pt) 2000-03-21
ATE302192T1 (de) 2005-09-15
EP0990650A4 (en) 2002-02-13
JP3410478B2 (ja) 2003-05-26
EP0990650B8 (en) 2005-10-19
EP0990650A1 (en) 2000-04-05
AU7674098A (en) 1998-12-30
CA2291651A1 (en) 1998-12-17
TW502024B (en) 2002-09-11
RU2191176C2 (ru) 2002-10-20
AU727654B2 (en) 2000-12-21
AU6989398A (en) 1998-12-17
ID23173A (id) 2000-03-23
DE69831236T2 (de) 2006-04-13
CN1203234A (zh) 1998-12-30
PL326777A1 (en) 1998-12-21
US6245796B1 (en) 2001-06-12
AR012952A1 (es) 2000-11-22
CN1097054C (zh) 2002-12-25
HU9801340D0 (en) 1998-08-28
KR19990006912A (ko) 1999-01-25

Similar Documents

Publication Publication Date Title
HUP9801340A1 (hu) Triciklusos pirazolszármazékok és az azokat tartalmazó gyógyszerkészítmények
DE69817393D1 (de) Neue heterozyklische verbindungen
CA2107014A1 (en) Therapeutic Agent for Parkinson's Disease
HUP0203509A2 (hu) Triciklusos pirazolkarbonsav-származékok, a vegyületek előállítása és a vegyületeket tartalmazó gyógyászati készítmények
ES2103479T3 (es) Derivados de anilida.
RU93004675A (ru) 1,2,4-оксадиазолил-феноксиалкилизоксазолы, их применение в качестве противовирусных агентов, фармацевтическая композиция
EP0371731A3 (en) Quinazolinone derivatives
HUP9802927A2 (hu) Alfa2-receptorokra ható imidazol-származékok, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
HUP9901652A2 (hu) Piperidin-karbonsav-származékok alkalmazása vérglükózkoncentráció csökkentésére alkalmas gyógyszerkészítmények előállítására
HUP0002830A2 (hu) Indol- és 2,3-dihidroindol-származékok, előállításuk és gyógyászati alkalmazásuk
TR200100378T2 (tr) P-maddesi aşırısının aracılık ettiği hastalıkların tedavisindeki ilaç
NO984106L (no) Azolobenzazepin-derivater som neurologisk aktive midler
ES2150353A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
TR199900138T2 (xx) Osteoporozun tedavisi i�in indolin t�revleri.
ES8103053A1 (es) Un procedimiento para preparar derivados de 2-imidazolina
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
DE69318563D1 (de) 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATE, IHRE HERSTELLUNG UND DIE SIE ENTHALTENDEN ARZNEIMITTEL
FR2508033B1 (hu)
ES8504731A1 (es) Un procedimiento para preparar antra 1,9-cd-7pirazol-6(2h)-onas
HUP9904696A2 (hu) COX-2 Enzim indén-típusú inhibitorai
ES8802052A1 (es) Un metodo para preparar derivados de 9-bencilpurina
HUP9900169A2 (hu) Immunoszuppresszáns hatású kinolin- vagy kinozalinszármazékok és ezeket tartalmazó gyógyászati készítmények
MXPA02002007A (es) Compuestos de bencimidazol sustituidos con alcoxi, preparaciones farmaceuticas que contienen los mismos, metodos para usarlos.